[Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic stem cell transplantation in Hodgkin's lymphoma].

Sorry, there's nothing here.

Cite this paper

@article{Shi2017ComparisonsOE, title={[Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic stem cell transplantation in Hodgkin's lymphoma].}, author={Yipeng Shi and P. L. Liu and S Y Zhou and Jing Yang and Xiao Hui Han and Xiang Hua He and C G Zhang and Lin Gui and Y Z Qin and S Yang and L Zhao and J R Yao and S X Zhang and Shunnian Wu and F Pan and Y. Sun and Ying Kang Shi}, journal={Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi}, year={2017}, volume={38 8}, pages={716-719} }